What is Tesamorelin?
Tesamorelin is a synthetic peptide that is structurally similar to growth hormone-releasing hormone (GHRH). It works by stimulating the pituitary gland to increase the body's natural production and release of growth hormone, which in turn increases insulin-like growth factor-1 (IGF-1). Tesamorelin has been studied for its effects on body composition and metabolism.
Tesamorelin is FDA-approved under the brand name Egrifta SV® for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. In other settings, its use may be considered off-label and should be discussed with a licensed healthcare provider.
Potential Areas of Interest
Clinical research has explored Tesamorelin in areas such as:
- Supporting healthy body composition when combined with proper nutrition and exercise
- Promoting the body's natural production of growth hormone
- Supporting lean muscle mass
- Supporting healthy metabolism
- Assisting with reduction of visceral (abdominal) fat in appropriately selected individuals
- Supporting exercise recovery
- Healthy aging and overall wellness
Individual responses vary, and maintaining healthy nutrition, regular exercise, adequate sleep, and other healthy lifestyle habits remain essential components of overall wellness.
Each vial will typically last one or two months.
processing. Shipping takes place Monday to Thursday.
This comes in a vial with syringes and will require the client to draw up and administer the medication.
You will be sent and given access to all education and protocols on purchase and medical clearance.
No guarantees for results as every person is different.
Not a candidate if having an active cancer or history of one in the last 6 months.
No refunds are available once medication is dispensed.